Well-educated women hardest hit by breast cancerOctober 20, 2009Well-educated women and those who live alone are emotionally the hardest hit by breast cancer, according to the findings of a new Australian study announced during October's Breast Cancer Awareness Month. The MBF Foundation Health and Wellbeing after Breast Cancer Study, undertaken by Monash University Medical School's Women's Health Program, found that older women tended to experience lower levels of overall wellbeing compared to women of similar age in the community two years after their diagnosis. "Up until now, there has been uncertainty about exactly what the impact of being diagnosed with breast cancer is in terms of mood and wellbeing over time. In our study, we found that two years post diagnosis women with breast cancer were not more likely to be depressed but were more likely to experience a lowered sense of control over their life, and lower general health, with lessened vitality being limited to older women," explains Dr Susan R Davis, Professor of Women's Health, Monash University Medical School, who was involved in the study. "The experience of having breast cancer is a personal one and is often accompanied by very complex emotions due to the fact that it strikes at a woman's very sense of self, purpose and sexuality." Co-chief investigator of the study, Associate Professor Robin Bell, added: "That women living alone were more likely to have a lower wellbeing is a novel and important finding and would suggest that such women may benefit by targeted provision of social support." More educated women are likely to be the best informed about their breast cancer and treatment, and their lower wellbeing results may reflect greater anxiety over decision making and their difficulty coping with a sense loss of control over their health and wellbeing. "We would encourage health care providers to be sensitive to the fact that more highly educated women may deal less well with psychological aspects of their disease than others," said Professor Davis. Breast cancer is the most common cancer among women in Australia, affecting one in nine women by the age of 85 years, and is responsible for around 2,600 deaths annually. With improvements in detection and treatment of breast cancer, 87 per cent of women affected survive five years or more from the time of detection. "At MBF Foundation we are all for women becoming advocates for their breast cancer and their health in general but, as this study has shown, it is important that providing accurate information isn't at the expense of supporting their emotional needs," commented Dr Christine Bennett, Bupa Australia Chief Medical Officer and Chair of the MBF Foundation steering committee, which has committed $300,000 to fund the study. "As survival prospects for women with breast cancer continue to improve, we shouldn't lose sight of the fact that each woman's journey and coping mechanisms are different. We know from listening to the women in the study, that it is common for breast cancer survivors to experience a range of emotions and concerns once treatment ends. Indeed, some women, report experiencing feelings of isolation and abandonment once their regular appointments with their medical team stop," added Dr Bennett. On a positive note, the study found that women's wellbeing two years out from being treated for the disease was overall only modestly lower than for Australian women in general. Research Australia |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. Breast density associated with increased risk of cancer recurrence A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation. Researcher: 'Optical biopsy' for breast cancer increasingly accurate But women may not have to endure the medical costs, stress and potential complications that accompany such invasive biopsies forever. A University of Florida biomedical engineering researcher is making progress on an "optical biopsy" that has the potential to determine whether growths are cancerous without ever puncturing the skin. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||